Riccio, Gennaro <br/><br/>
Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents.  [electronic resource] 

 -  FASEB journal : official publication of the Federation of American Societies for Experimental Biology  Sep 2009 
 - 3171-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1530-6860 
<br/><br/><label>Standard No.: </label>10.1096/fj.09-131383  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Breast Neoplasms--complications<br/>Cardiotoxins<br/>DNA Fragmentation--drug effects<br/>Drug-Related Side Effects and Adverse Reactions<br/>Electrocardiography<br/>Fibrosis--chemically induced<br/>Humans<br/>Mice<br/>Protein Engineering--methods<br/>Receptor, ErbB-2--immunology<br/>Trastuzumab